Review of Direct Oral Anticoagulants and Guide for Effective Drug Utilization

被引:0
作者
Tigran Khachatryan
Christopher Hauschild
Jason Hoff
Tahmeed Contractor
Arthur Khachatryan
Huyentran Tran
Bert Matsuo
Alan Jacobson
Anthony Hilliard
机构
[1] Loma Linda University Medical Center,International Heart Institute
[2] University of Nevada,Reno School of Medicine
[3] VA Loma Linda Health Care Systems,Department of Cardiology
来源
American Journal of Cardiovascular Drugs | 2019年 / 19卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Direct oral anticoagulants (DOACs) have been developed as a viable and in some cases superior alternative to warfarin. These agents have overcome some of the limitations of warfarin, which has a narrow therapeutic window and many food and drug interactions. DOACs have been demonstrated to have a more predictable and reliable pharmacology and, unlike warfarin, do not require frequent monitoring of anticoagulant effect. For these reasons, the use of DOACs is increasing. Despite the many positive attributes of these agents, limitations and contraindications do exist. An understanding of the pharmacology, indications, and contraindications is therefore crucial for effective patient management. We review the available agents to aid in effective drug utilization.
引用
收藏
页码:525 / 539
页数:14
相关论文
共 50 条
  • [21] Drug-drug interactions between direct oral anticoagulants and anticonvulsants and clinical outcomes: A systematic review
    Candeloro, Matteo
    Carlin, Stephanie
    Shapiro, Michelle J.
    Douketis, James D.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (03)
  • [22] Direct Oral Anticoagulants in Patients with Cirrhosis Appear Safe and Effective
    Kunk, Paul R.
    Collins, Hampton
    Palkimas, Surabhi
    Intagliata, Nicolas M.
    Maitland, Hillary S.
    BLOOD, 2016, 128 (22)
  • [23] DIRECT ORAL ANTICOAGULANTS ARE EFFECTIVE AND SAFE IN PATIENTS WITH GYNECOLOGIC CANCER
    Shimizu, A.
    Sawada, K.
    SHiomi, M.
    Kawano, M.
    Takiuchi, T.
    Yuri, M.
    Kodama, M.
    Kobayashi, E.
    Hashimoto, K.
    Mabuchi, S.
    Ueda, Y.
    Tomomastu, T.
    Kimura, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 564 - 564
  • [24] Genetic Testing to Guide Warfarin Dosing: Impact of Direct Oral Anticoagulants
    Lentz, S. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (02) : 128 - 130
  • [25] Levetiracetam interaction with direct oral anticoagulants - A systematic review
    Roesche, J.
    Shah, Y.
    EPILEPSIA, 2024, 65 : 461 - 461
  • [26] Direct oral anticoagulants: a review of common medication errors
    Drakeria Barr
    Quovadis J. Epps
    Journal of Thrombosis and Thrombolysis, 2019, 47 : 146 - 154
  • [27] Direct Oral Anticoagulants in Obesity: An Updated Literature Review
    Sebaaly, Jamielynn
    Kelley, Denise
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (11) : 1144 - 1158
  • [28] Direct oral anticoagulants: a review of common medication errors
    Barr, Drakeria
    Epps, Quovadis J.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 47 (01) : 146 - 154
  • [29] Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: A systematic review
    Li, Allen
    Li, Ming K.
    Crowther, Mark
    Vazquez, Sara R.
    THROMBOSIS RESEARCH, 2020, 194 : 240 - 245
  • [30] Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review
    Adcock, D. M.
    Gosselin, R.
    THROMBOSIS RESEARCH, 2015, 136 (01) : 7 - 12